Induction chemotherapy with cemiplimab in a patient with coexistent vulvar cancer and autoimmune disease: A case report

• Main Authors: Elizabeth G. Thayer (Author), M. Larissa Weirich (Author), Zoe A. Roecker (Author), Sara E. Brenner (Author), Jill S. Remick (Author), Ashish B. Patel (Author), Kristen D. Starbuck (Author)
• Format: Book
• Published: Elsevier, 2024-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

There is limited data regarding the use of immunotherapy for patients with vulvar squamous cell carcinoma and coexisting autoimmune disease. Cemiplimab is a PD-1 inhibitor approved for use in patients with locally advanced and metastatic cutaneous squamous cell carcinoma. However, little is known ab...